Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II

Chad A. Hamilton; Bhavana Pothuri; Rebecca C. Arend; Floor J. Backes; Paola A. Gehrig; Pamela T. Soliman; J. Spencer Thompson; Renata R. Urban; William M. Burke

doi:10.1016/j.ygyno.2020.12.024

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II

Chad A. Hamilton, Bhavana Pothuri, Rebecca C. Arend, Floor J. Backes, Paola A. Gehrig, Pamela T. Soliman, J. Spencer Thompson, Renata R. Urban, William M. Burke

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Abstract

In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. This manuscript, Part II in a two-part series, includes specific recommendations on treatment of recurrent disease, post treatment surveillance and survivorship, considerations for younger women, and special situations. Part I covered histopathology and molecular pathology, risk factors, presentation and diagnostic approach, surgical approach and adjuvant therapy.

Original language	English (US)
Pages (from-to)	827-834
Number of pages	8
Journal	Gynecologic oncology
Volume	160
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2020.12.024
State	Published - Mar 2021

Keywords

Considerations for younger women
Post treatment surveillance
Survivorship
Treatment of recurrent disease

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2020.12.024

Cite this

@article{250c29ab539e45f3bf83174c193a4fc9,

title = "Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II",

abstract = "In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. This manuscript, Part II in a two-part series, includes specific recommendations on treatment of recurrent disease, post treatment surveillance and survivorship, considerations for younger women, and special situations. Part I covered histopathology and molecular pathology, risk factors, presentation and diagnostic approach, surgical approach and adjuvant therapy.",

keywords = "Considerations for younger women, Post treatment surveillance, Survivorship, Treatment of recurrent disease",

author = "Hamilton, {Chad A.} and Bhavana Pothuri and Arend, {Rebecca C.} and Backes, {Floor J.} and Gehrig, {Paola A.} and Soliman, {Pamela T.} and Thompson, {J. Spencer} and Urban, {Renata R.} and Burke, {William M.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2021",

month = mar,

doi = "10.1016/j.ygyno.2020.12.024",

language = "English (US)",

volume = "160",

pages = "827--834",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Endometrial cancer

T2 - A society of gynecologic oncology evidence-based review and recommendations, part II

AU - Hamilton, Chad A.

AU - Pothuri, Bhavana

AU - Arend, Rebecca C.

AU - Backes, Floor J.

AU - Gehrig, Paola A.

AU - Soliman, Pamela T.

AU - Thompson, J. Spencer

AU - Urban, Renata R.

AU - Burke, William M.

PY - 2021/3

Y1 - 2021/3

N2 - In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. This manuscript, Part II in a two-part series, includes specific recommendations on treatment of recurrent disease, post treatment surveillance and survivorship, considerations for younger women, and special situations. Part I covered histopathology and molecular pathology, risk factors, presentation and diagnostic approach, surgical approach and adjuvant therapy.

AB - In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. This manuscript, Part II in a two-part series, includes specific recommendations on treatment of recurrent disease, post treatment surveillance and survivorship, considerations for younger women, and special situations. Part I covered histopathology and molecular pathology, risk factors, presentation and diagnostic approach, surgical approach and adjuvant therapy.

KW - Considerations for younger women

KW - Post treatment surveillance

KW - Survivorship

KW - Treatment of recurrent disease

UR - http://www.scopus.com/inward/record.url?scp=85099870188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099870188&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2020.12.024

DO - 10.1016/j.ygyno.2020.12.024

M3 - Review article

C2 - 33451724

AN - SCOPUS:85099870188

SN - 0090-8258

VL - 160

SP - 827

EP - 834

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 3

ER -

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this